- 現金殖利率: 31.69%、總殖利率: 31.69%、5年平均現金配發率: 635.86%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 (5) | 0.51 | -79.01 | 5.64 | 39.95 | 0.00 | 0 | 1105.88 | 566.82 | 0.00 | 0 | 1105.88 | 566.82 |
| 2024 (4) | 2.43 | -76.32 | 4.03 | 0 | 0.00 | 0 | 165.84 | 0 | 0.00 | 0 | 165.84 | 0 |
| 2023 (3) | 10.26 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 26Q1 (8) | 0.13 | -31.58 | -92.57 | 0.03 | -75.0 | 200.0 | 0.13 | -74.51 | -92.57 |
| 25Q4 (7) | 0.19 | -82.08 | -84.92 | 0.12 | 50.0 | 0.0 | 0.51 | -85.17 | -79.01 |
| 25Q3 (6) | 1.06 | 63.08 | 32.5 | 0.08 | 100.0 | 100.0 | 3.44 | 43.33 | 158.65 |
| 25Q2 (5) | 0.65 | -62.86 | 14.04 | 0.04 | 300.0 | 0.0 | 2.40 | 37.14 | 1900.0 |
| 25Q1 (4) | 1.75 | 38.89 | 0.0 | 0.01 | -91.67 | 0.0 | 1.75 | -27.98 | 0.0 |
| 24Q4 (3) | 1.26 | 57.5 | 0.0 | 0.12 | 200.0 | 0.0 | 2.43 | 82.71 | 0.0 |
| 24Q3 (2) | 0.80 | 40.35 | 0.0 | 0.04 | 0.0 | 0.0 | 1.33 | 1008.33 | 0.0 |
| 24Q2 (1) | 0.57 | 0.0 | 0.0 | 0.04 | 0.0 | 0.0 | 0.12 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 1.72 | -9.44 | 40.46 | 6.36 | 39.06 | 4.97 | N/A | - | ||
| 2026/3 | 1.9 | 39.83 | 40.91 | 4.64 | 38.55 | 4.64 | 0.92 | - | ||
| 2026/2 | 1.36 | -1.94 | 18.66 | 2.74 | 36.96 | 4.57 | 0.94 | - | ||
| 2026/1 | 1.38 | -24.37 | 61.35 | 1.38 | 61.35 | 6.58 | 0.65 | 大研醫美系列第一款保濕除皺外泌體精華液、納豆紅麴Q10等新品熱銷,營收年增61%,展現產品力與品牌實力。 | ||
| 2025/12 | 1.83 | -45.68 | 30.69 | 18.95 | 38.57 | 6.56 | 0.63 | - | ||
| 2025/11 | 3.37 | 147.32 | 16.58 | 17.12 | 39.47 | 6.26 | 0.66 | - | ||
| 2025/10 | 1.36 | -10.93 | 13.4 | 13.75 | 46.51 | 4.36 | 0.95 | - | ||
| 2025/9 | 1.53 | 4.0 | 45.5 | 12.39 | 51.37 | 0.0 | N/A | 大研倍利他命與超級薑黃等新品、官網AI營運、四大電商銷冠、實體通路擴張,營收年增51%,彰顯新品研發力、品牌力與數據力。 | ||
| 2025/8 | 1.47 | -1.53 | 43.12 | 10.86 | 52.24 | 0.0 | N/A | 大研八四魚油日,官網AI營銷研發奏效,四大電商銷量第一,營收年增52%,展現品牌力與數據實力。 | ||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A |
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。